Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
LCNB Corp
LCNB
$282M
| $165K | ﹤0.01% |
11,046
| – | – |
|
3402
UFP Technologies
UFPT
$2.43B
| $164K | ﹤0.01% |
2,063
-783
| -28% | -$57.5K |
|
|
ITIC
3403
Investors Title Co
ITIC
$542M
| $163K | ﹤0.01% |
1,042
-212
| -17% | -$36.4K |
|
3404
Puma Biotechnology
PBYI
$436M
| $163K | ﹤0.01% |
57,066
-5,242
| -8% | -$13K |
|
|
DAO
3405
Youdao
DAO
$2.14B
| $162K | ﹤0.01% |
+33,000
| New | +$197K |
|
3406
MillerKnoll
MLKN
$1.66B
| $162K | ﹤0.01% |
6,186
-10,408
| -63% | -$315K |
|
3407
ProShares UltraPro Short S&P 500
SPXU
$389M
| $162K | ﹤0.01% |
400
| – | – |
|
3408
Modine Manufacturing
MOD
$10.4B
| $161K | ﹤0.01% |
15,326
-2,705
| -15% | -$25.6K |
|
3409
Corsair Gaming
CRSR
$1.5B
| $160K | ﹤0.01% |
12,164
-15,088
| -55% | -$246K |
|
3410
DXP Enterprises
DXPE
$3.08B
| $160K | ﹤0.01% |
5,246
-9,209
| -64% | -$253K |
|
3411
FirstService
FSV
$6.32B
| $160K | ﹤0.01% |
1,318
+1,016
| +336% | +$128K |
|
3412
Inogen
INGN
$163M
| $160K | ﹤0.01% |
6,597
-9,808
| -60% | -$261K |
|
|
RUTH
3413
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $160K | ﹤0.01% |
9,817
-15,798
| -62% | -$304K |
|
|
CCC
3414
CCC Intelligent Solutions
CCC
$3.97B
| $159K | ﹤0.01% |
17,298
+17,147
| +11,356% | +$158K |
|
|
CNSL
3415
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $159K | ﹤0.01% |
22,752
-35,318
| -61% | -$232K |
|
3416
Benitec Biopharma
BNTC
$459M
| $158K | ﹤0.01% |
8,018
+4,565
| +132% | +$106K |
|
3417
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $158K | ﹤0.01% |
16,372
-3,289
| -17% | -$30.7K |
|
3418
iShares MSCI Germany ETF
EWG
$1.62B
| $157K | ﹤0.01% |
6,811
-18,251
| -73% | -$475K |
|
|
MRSN
3419
DELISTED
Mersana Therapeutics
MRSN
| $157K | ﹤0.01% |
1,363
-300
| -18% | -$28.2K |
|
3420
StepStone Group
STEP
$4.02B
| $157K | ﹤0.01% |
6,024
-5,188
| -46% | -$141K |
|
3421
Ennis
EBF
$564M
| $156K | ﹤0.01% |
7,724
-2,991
| -28% | -$53.9K |
|
|
OLO
3422
DELISTED
Olo Inc
OLO
| $156K | ﹤0.01% |
15,765
+5,801
| +58% | +$63.2K |
|
3423
Hyliion Holdings
HYLN
$708M
| $155K | ﹤0.01% |
48,330
-65,416
| -58% | -$229K |
|
|
SEMR
3424
DELISTED
Semrush
SEMR
| $155K | ﹤0.01% |
12,000
| – | – |
|
3425
Grupo Cibest SA
CIB
$21.1B
| $154K | ﹤0.01% |
4,999
+4,916
| +5,923% | +$194K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.